Table 3.
Summary of baseline demographics NR – Not reported; SD – Standard Deviation; CM- Cardiomyopathy; HTN – Hypertension; BMI – Body Mass Index; AF- Atrial Fibrillation; HR – Heart Rate; IHD – Ischemic Heart Disease; HF- Heart failure; CKD – Chronic Kidney Disease; eGFR – estimated glomerular filtration rate; NYHA – New York Heart Association; MWT – Metre Walk Test; BB- Beta-blocker; ARB – Angiotensin receptor Blocker; ACE-I – Angiotensin Converting Enzyme-Inhibitor; MRA- Mineralocorticoid receptor antagonist.
| Study | BB (%) | ACE/ARB (%) | MRA (%) | Statin (%) | Diuretics (%) | Antiplatelet (%) | Digoxin (%) |
|---|---|---|---|---|---|---|---|
| Khidir et al. (2018) [13] | 632 (76) | 733 (88) | 364 (44) | 517 (62) | 652 (79) | 672 (81%) | NR |
| Bax et al. (2017) [15] | 728 (90) | 719 (89) | 451 (56) | NR | NR | NR | NR |
| Hasselberg et al. (2016) [14] | 157 (92) | 160 (94) | 67 (39) | NR | 142 (84) | NR | 18 (11) |
| Delgado-Montero et al. (2016) [16] | 179 (87) | 186 (91) | NR | NR | NR | NR | NR |
| Van Der Bijl et al. (2019) [21] | 833 (70.3) | 994 (83.9) | 493 (41.6) | NR | 891 (75.2) | NR | 168 (14.2) |
| Knappe et al. (2011) [18] | NR | NR | NR | NR | NR | NR | NR |
| Menet et al. (2016) [19] | NR | NR | NR | NR | NR | NR | NR |
| Kalogeropoulos et al. (2011) [17] | 44 (77.2) | 46 (80.7) | 22 (38.6) | NR | NR | NR | NR |
| Park et al. (2013) [20] | 283 (84.7) | 275 (82.3) | 100 (29.9) | NR | 267 (79.9) | NR | NR |